How big is the Breast Cancer Drugs Market ?
Global Breast Cancer Drugs Market reached USD 28.7 billion in 2022 and is projected to witness lucrative growth by reaching USD 57.1 billion by 2031.
Who are the key players in Breast Cancer Drugs Market ?
Major players are Novartis AG, F. Hoffmann-La Roche Ltd., AbbVie, Inc., Eli Lilly and Company, AstraZeneca, Merck & Co., Inc., Biocon Genzyme Corporation, MacroGenics, Inc., Janssen Global Services LLC, and Onyx Pharmaceuticals Inc.